Antepartum Monitors Market Size
Antepartum Monitors Market Analysis
The Antepartum Monitors Market size is estimated at USD 2.74 billion in 2025, and is expected to reach USD 4.05 billion by 2030, at a CAGR of 8.12% during the forecast period (2025-2030).
Antepartum monitors are critical diagnostic tools utilized during the second and third trimesters to evaluate fetal health, manage high-risk pregnancies, and reduce neonatal mortality. These devices are instrumental in the early detection of fetal complications, maternal health conditions (such as mental health disorders and gestational diabetes), and undiagnosed congenital abnormalities. The rising prevalence of pregnancy complications is a key driver of market growth. For instance, a 2024 article published by the National Library of Medicine reported that approximately 10% of pregnant women and 13% of new mothers globally experienced mental health issues in 2024, with depression being the most common. In developing countries, these rates were even higher, reaching 15.6% during pregnancy and 19.8% after childbirth in 2024. The increasing complexity of pregnancies, as evidenced by the growing incidence of mental health challenges, highlights the urgent need for advanced diagnostic tools. This rising demand is directly contributing to the adoption of antepartum monitors, which are essential for addressing these complications and supporting maternal and fetal health, further driving the market.
Awareness of maternal and fetal health has significantly increased in recent years, further supporting the adoption of antepartum monitors. In July 2023, the Texas Department of State Health Services (DSHS), in collaboration with Northeast Texas Public Health District (NETHealth), UT-CHWI, and the University of Texas Health Science Center in Houston (UTHSCH), launched the High-Risk Maternal Care Coordination Services Program (HRMCCSP) pilot. This initiative identifies pregnant and postpartum women in Smith County at risk of adverse pregnancy, birth, or postpartum outcomes and provides education, care coordination, and referrals to mitigate these risks. Such programs emphasize the importance of monitoring and managing maternal and fetal health, thereby boosting market growth.
The antepartum monitors market is also witnessing rapid technological advancements, with manufacturers focusing on improving maternal comfort, mobility, and monitoring precision. In January 2023, Huntleigh Healthcare introduced the Sonicaid Team3 Wireless System, a cutting-edge fetal monitoring device designed to enhance maternal comfort and monitoring accuracy. This system incorporates wire-free ultrasound transducers for fetal heart rate monitoring and a TOCO transducer that securely attaches to the mother's abdomen to measure uterine activity. These innovations are propelling the antepartum monitors market growth by addressing key user needs and advancing product capabilities.
In conclusion, the rising complexities in pregnancies, increasing awareness of maternal and fetal health, and technological advancements are collectively driving the growth of the antepartum monitors market. These factors are expected to sustain market expansion in the coming years. However, the market faces challenges such as the high costs of antepartum monitoring systems, stringent regulatory requirements, limited access to fetal monitors, and a shortage of skilled professionals, which are restraining its growth.
Antepartum Monitors Market Trends
Ultrasound Devices Product Type Segment is Expected to Witness Significant Growth Over the Forecast Period
Ultrasound devices are fundamental to antepartum monitoring, providing critical insights into the fetus, placenta, and uterus. These insights are vital for assessing fetal health, determining gestational age, and identifying potential complications. During fetal ultrasounds, healthcare providers evaluate key aspects such as the baby's heart, head, spine, and other essential parts. The procedure can be performed either transabdominally on the mother's abdomen or transvaginally. Various types of fetal ultrasounds, including standard, Doppler, and 3-D, are utilized to ensure comprehensive assessments. The increasing reliance on these devices for accurate and timely fetal evaluations is a significant driver of growth in the antepartum monitors market.
Moreover, technological advancements, particularly the integration of artificial intelligence (AI), are transforming ultrasound devices by enhancing obstetric measurements and early fetal scans. For instance, in November 2023, Royal Philips, a healthcare technology company, secured USD 60 million in funding from the Bill & Melinda Gates Foundation. This funding is aimed at accelerating the global adoption of AI algorithms on Philips' Lumify Handheld Ultrasound. By leveraging AI to simplify critical measurements for detecting pregnancy abnormalities, the training time required to operate the system has been reduced from weeks to hours. This innovation is expected to expand the accessibility of advanced ultrasound technology among frontline health workers, thereby driving the growth of the antepartum monitors market in the forecasted period.
Additionally, portable ultrasound machines are transforming antepartum care by enabling early complication detection, improving access to critical information, and supporting healthcare providers and expectant parents in underserved areas. In May 2024, University Hospitals (UH) MacDonald Women’s Hospital launched a mobile obstetrics imaging unit in Portage and Lorain countries, focusing on fetal ultrasound. This initiative expanded Maternal-Fetal Medicine (MFM) services, addressing care gaps and improving access to specialized care. Nationwide, advancements in prenatal care and fetal imaging, particularly in regions like Northeast Ohio, have reduced pregnancy risks such as high blood pressure and preterm births. These developments are accelerating the growth of the antepartum monitors market.
Furthermore, advanced ultrasound technologies are playing a pivotal role in improving antepartum monitoring by enhancing the detection and management of high-risk pregnancies. This progress is exemplified by a case study conducted in South Africa, published by the National Library of Medicine in May 2023. The study evaluated the effectiveness of continuous-wave Doppler ultrasound (CWDU) by screening 7,088 low-risk pregnant women across 19 antenatal clinics at nine sites using the Umbiflow CWDU device. The results demonstrated that integrating CWDU into routine antenatal care is both feasible and effective when supported by adequate resources, maternal and neonatal facilities, and established treatment protocols. These findings highlight how advancements in CWDU technology are driving the adoption of ultrasound devices, which, in turn, is contributing to the overall growth of the market.
In conclusion, the integration of advanced technologies and the increasing accessibility of ultrasound devices are key factors propelling the growth of the ultrasound devices segment in the antepartum monitors market. These innovations are addressing critical gaps in prenatal care and improving maternal and fetal health outcomes globally.
North America is Expected to Hold a Significant Share in the Antepartum Monitors Market
North America is positioned to lead the antepartum monitors market, driven by government initiatives to enhance maternal and fetal health, advancements in monitoring technologies, tele-ultrasound adoption, and the presence of key players. For example, the United States has introduced innovative fetal monitoring solutions for monitoring approximately 95% of all eligible births in the region. In February 2024, GE HealthCare received FDA 510(k) clearance for its Novii+ Wireless Patch Solution, which noninvasively monitors fetal and maternal heart rates and uterine activity, providing real-time data. Its wireless, belt-free design improves maternal mobility and comfort during labor. These technological advancements are enhancing patient outcomes and care delivery, significantly propelling the growth of the antepartum monitors market in the region.
Moreover, the U.S. government has also implemented measures to address fetal health challenges and reduce prenatal mortality and stillbirth rates. In October 2024, the National Institutes of Health announced the winners of the RADx Tech Fetal Monitoring Challenge, a USD 2 million competition designed to accelerate the development of innovative medical technologies for fetal health diagnosis, detection, and monitoring. This initiative specifically targets high stillbirth rates and poor fetal health outcomes. By fostering advancements in diagnostic technology, the challenge enables earlier and more accurate detection of fetal health issues, facilitating timely medical interventions. These efforts are further driving the growth of the antepartum monitors market by addressing critical healthcare needs.
Additionally, the integration of telehealth with ultrasound is addressing healthcare accessibility challenges in rural areas, further supporting market growth. In May 2024, Dr. Michael Ruma, a maternal-fetal medicine specialist at Perinatal Associates of New Mexico, utilized the Philips EPIQ Ultrasound System with Collaboration Live for remote diagnostics. This approach allowed real-time interaction with patients and staff, resulting in over 8,000 pregnancy scans in 2023 and enabling complex diagnoses through telehealth. By reducing the need for in-person prenatal visits and enhancing diagnostic efficiency, these advancements are increasing the demand for remote monitoring solutions, further propelling the market growth.
In conclusion, North America's robust healthcare infrastructure, coupled with technological advancements and government initiatives, positions the region as a leader in the antepartum monitors market. These factors are expected to sustain its dominance during the forecast period.
Antepartum Monitors Industry Overview
The antepartum monitors market is semi-consolidated in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold significant market share and are well known include GE HealthCare Technologies Inc., Koninklijke Philips N.V., Huntleigh Healthcare Ltd., Contec Medical Systems Co.,Ltd, and Nemo Healthcare B.V., among others.
Antepartum Monitors Market Leaders
-
GE HealthCare Technologies Inc.
-
Koninklijke Philips N.V.
-
Huntleigh Healthcare Ltd.
-
Contec Medical Systems Co.,Ltd.
-
Nemo Healthcare B.V.
- *Disclaimer: Major Players sorted in no particular order
Antepartum Monitors Market News
- October 2024: In October 2024, Comen introduced two advanced fetal and maternal monitors, the CF5 and CF8. These devices are engineered to deliver enhanced monitoring precision, improved connectivity, and greater flexibility for both mothers and clinicians. This launch underscores the company's dedication to advancing innovation in prenatal care.
- June 2024: In June 2024, Clarius Mobile Health obtained U.S. Food and Drug Administration (FDA) clearance for its Clarius OB AI fetal biometric measurement tool. As the company's 8th AI model, this tool is designed to expand access to prenatal monitoring and care, particularly in resource-constrained regions. This development further solidifies Clarius Mobile Health's position in the market.
Antepartum Monitors Industry Segmentation
As per the scope of the study, antepartum monitors helps in assessing fetal well-being, identifying treatable conditions that may lead to complications, and evaluating chromosomal abnormalities. These tests are classified into two categories including screening tests and diagnostic tests. Screening tests include cell-free DNA testing, serum analyte testing, and nuchal translucency measurements, which help detect potential risks. Diagnostic tests, such as chorionic villus sampling (CVS) and amniocentesis, provide definitive diagnoses of aneuploidy.
The antepartum monitors market is segmented into product type, portability, end-user, and geography. By product type, the market is segmented into fetal doppler devices, telemetry devices, ultrasound devices, electronic maternal/fetal monitors, and fetal spiral electrodes. By portability, the market is segmented into portable systems and non-portable systems. By end-user, the market is segmented into hospitals, obstetrics & gynecology clinics, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also offers the market size and forecasts for 17 countries across the region. For each segment, the market sizing and forecasts have been done on the basis of revenue (USD).
By Product | Fetal Doppler Devices | ||
Telemetry Devices | |||
Ultrasound Devices | |||
Electronic Maternal/Fetal Monitors | |||
Fetal Spiral Electrodes | |||
By Portability | Portable Systems | ||
Non-portable Systems | |||
By End-User | Hospitals | ||
Obstetrics & Gynecology Clinics | |||
Others | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Fetal Doppler Devices |
Telemetry Devices |
Ultrasound Devices |
Electronic Maternal/Fetal Monitors |
Fetal Spiral Electrodes |
Portable Systems |
Non-portable Systems |
Hospitals |
Obstetrics & Gynecology Clinics |
Others |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle East and Africa | GCC |
South Africa | |
Rest of Middle East and Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Antepartum Monitors Market Research FAQs
How big is the Antepartum Monitors Market?
The Antepartum Monitors Market size is expected to reach USD 2.74 billion in 2025 and grow at a CAGR of 8.12% to reach USD 4.05 billion by 2030.
What is the current Antepartum Monitors Market size?
In 2025, the Antepartum Monitors Market size is expected to reach USD 2.74 billion.
Who are the key players in Antepartum Monitors Market?
GE HealthCare Technologies Inc., Koninklijke Philips N.V., Huntleigh Healthcare Ltd., Contec Medical Systems Co.,Ltd. and Nemo Healthcare B.V. are the major companies operating in the Antepartum Monitors Market.
Which is the fastest growing region in Antepartum Monitors Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Antepartum Monitors Market?
In 2025, the North America accounts for the largest market share in Antepartum Monitors Market.
What years does this Antepartum Monitors Market cover, and what was the market size in 2024?
In 2024, the Antepartum Monitors Market size was estimated at USD 2.52 billion. The report covers the Antepartum Monitors Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Antepartum Monitors Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Antepartum Monitors Industry Report
Statistics for the 2025 Antepartum Monitors market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Antepartum Monitors analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.